[
  {
    "ts": null,
    "headline": "How Waters’ (WAT) Surging Pharma Demand and Revenue Beat Could Reshape Its Investment Narrative",
    "summary": "Waters Corporation recently reported a strong quarter, with an 8.9% year-over-year increase in revenue that surpassed analysts' expectations by 3.3%, fueled by robust instrument replacement demand from large pharmaceutical and CDMO customers. This performance stands out even more given a contrasting weaker quarter reported by peer Bruker, highlighting Waters' momentum in core life sciences markets. With Waters outperforming analyst expectations thanks to significant pharma and CDMO...",
    "url": "https://finnhub.io/api/news?id=64d279a8b0df47ecd86f42a4231ee8341747bc0f3ec0b19a53bd9b5a09a9e2e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756548620,
      "headline": "How Waters’ (WAT) Surging Pharma Demand and Revenue Beat Could Reshape Its Investment Narrative",
      "id": 136581389,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Waters Corporation recently reported a strong quarter, with an 8.9% year-over-year increase in revenue that surpassed analysts' expectations by 3.3%, fueled by robust instrument replacement demand from large pharmaceutical and CDMO customers. This performance stands out even more given a contrasting weaker quarter reported by peer Bruker, highlighting Waters' momentum in core life sciences markets. With Waters outperforming analyst expectations thanks to significant pharma and CDMO...",
      "url": "https://finnhub.io/api/news?id=64d279a8b0df47ecd86f42a4231ee8341747bc0f3ec0b19a53bd9b5a09a9e2e5"
    }
  }
]